During development, neural circuits are initially generated by exuberant innervation and are rapidly refined by selective preservation and elimination of axons. The establishment and maintenance of functional circuits therefore requires coordination of axon survival and degeneration pathways. Both developing and mature circuits rely on interdependent mitochondrial and cytoskeletal components to maintain axonal health and homeostasis; injury or diseases that impinge on these components frequently cause pathologic axon loss. Here, we review recent findings that identify mechanisms of axonal preservation in the contexts of development, injury, and disease.
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Establishing and maintaining circuits Functional neural circuits depend on proper interconnections formed by long-range axonal projections. As the fundamental connective unit of neural circuits, axons must be protected and maintained in the face of multiple potential threats. Axonal maintenance is particularly important because most neurons cannot be replaced and must therefore be preserved throughout the life of the organism. Axon degeneration is a broad term applied to various modes of axon death, with distinct instigators but similar final morphology of axon fragmentation. Although much progress has been made toward elucidating the mechanisms underlying axonal degeneration, a complete understanding requires study of the mechanisms opposing degeneration. Axon regeneration, the recovery and regrowth of axons following acute or chronic trauma, is not the opposite of axon degeneration, but rather a response to it. In reality the opposite of axon degeneration is the process of axonal survival.
It was classically thought that axons degenerate as a result of cell body death, due to a lack of support from the cell body. This theory was first challenged by the discovery of the Wallerian degeneration slow (Wld 
Feature Review
Glossary Apaf-1 (apoptotic protease activating factor 1): a key constituent of the apoptotic machinery that binds cytochrome c and subsequently activates caspase-9. Bcl-w (Bcl-2-like protein 2): a pro-survival Bcl-2 family member that binds proapoptotic Bcl-2 family members to prevent initiation of the axonal apoptotic caspase cascade [4] . Calpains: a family of calcium-activated cysteine proteases that degrade cytoskeletal components and are activated in both developmental and pathological axon degeneration [30] . Calpastatin: an endogenous calpain inhibitor, which is degraded during developmental and pathological axon degeneration [30] . Caspases (cysteine-aspartic proteases): a family of cysteine proteases essential for cell body apoptosis and developmental axon degeneration. Caspases are first synthesized as inactive pro-caspases, which are activated upon cleavage. DLK (dual leucine zipper kinase): a mitogen-activated protein kinase kinase kinase (MAPKKK) involved in axon degeneration and regeneration [92] [93] [94] [95] [96] [97] . Its Drosophila ortholog is Wallenda. DR6 (death receptor 6): a tumor necrosis factor (TNF) receptor whose activation induces apoptosis and axon degeneration [27, 45] . IMPA1 (myo-inositol monophosphatase-1): an enzyme involved in synthesis of myo-inositol and therefore essential for phosphophatidylinositol signaling pathways such as neurotrophin signaling. Lamin B2: a component of the nuclear skeleton that also localizes to axons and is essential for axon maintenance [75] . MEC-17 (mechanosensory abnormality 17): an enzyme that catalyzes tubulin acetylation, a posttranslational modification, and which also stabilizes microtubules and preserves axons independent of its acetyltransferase activity [83] . Neurotrophins: a family of secreted growth factors that promote axonal and neuronal survival by binding to transmembrane tropomyosin receptor kinase (Trk) receptors. NMNAT (nicotinamide mononucleotide adenylyltransferase): a family of NAD + biosynthetic enzymes involved in axon maintenance, and a component of the Wld S fusion gene. 
